Appointed
2024

Education & Fellowships

Residency - Case Western Reserve University (MetroHealth) Program
Pediatrics
Cleveland, OH
2005

Fellowship - Case Western Reserve University (MetroHealth) Program
Neonatal-Perinatal Medicine (Pediatrics)
Cleveland, OH
2002

Medical Education - Damascus University Faculty of Medicine
Damascus,
1986

Additional Training

• Summer 2002                Successfully completed the course of Introduction to Clinical Research,
   Case Western Reserve University, Cleveland. OH, USA.

  9/1/2000-6/30/2001      Successfully completed the two semester course on Research Design and
                                       Biostatistics. MetroHealth Medical Center, Case Western Reserve University,
                                       Cleveland, OH. 

  4/16/1989-4/15/1991:   Pediatric Residency Training (First Pediatric Residency):                                          

                                       Alwasl Hospital, Department of Health and Medical Services, Dubai, UAE.

                                       

Professional Highlights

• Professional Appointments: 

   

  2011- Present:    Neonatology staff, Neonatology Department,  Cleveland Clinic Foundation, Cleveland, Ohio.
   
  2007- 2011:       Consultant Neonatologist, Pediatric Department, NICU, Tawam Hospital in affiliation with

                            Johns Hopkins Medicine. Al Ain, United Arab Emirates.
                            Clinical Assistant Professor, Faculty of Health and Medical Science,  
                            United Arab Emirates University, Alain, UAE.
                            Neonatology Consultant and lecturer, Syria 
  2006                  Chief of Service, Neonatal Intensive Care Unit. The Governor Juan F. Luis Hospital,
                            Christiansted, St. Croix, Virgin Islands, U.S.A.

  2002 - 2005       Pediatric Residency, Pediatric Department, MetroHealth  Medical Center,
                            Case Western Reserve University, Cleveland, OH         
  1999- 2002       Neonatology Fellowship. Neonatal-Perinatal Medicine Fellow,  

                            Neonatology Division, Pediatric Department, MetroHealth

                            Medical Center, Case Western Reserve University, Cleveland, OH                                      

  1996-1999        Senior House Officer, Level III Neonatal Intensive Care Unit,

                            Dubai Hospital, Dubai, United Arab Emirates.

  1991-1996        Senior House Officer, General Pediatrics and Neonatology,

                            Dubai Hospital, Department of Health and Medical Services

                            Dubai, United Arab Emirates.

Certifications

• Pediatrics
• Pediatrics - Neonatal-Perinatal Medicine

Awards & Honors

• Excellence of Teaching Award in 2009-2010 academic year, Faculty of Medicine and Health Science, UAE University.
• Physician Recognition Award, American Medical Association (2002–2005).
• Medical School Scholarship from United Arab Emirates Embassy, Damascus, Syria (1981- 1986).
• The first in the elementary and primary schools, and among the first ten in the high school.

Innovations & Patents

• Publications
  

  ·        M. M. Tamim, Hassan Alesseh and Hany Aziz: (Analysis of the Efficacy of Urine Culture as Part of Sepsis Evaluation in the Premature Infant), the Pediatric Infectious Disease Journal, Vol.22, No. 9, Sept. 2003.

  ·        Abdulla Gori, M. Tamim and John Moore: Fetomaternal Hemorrhage, Pediatric in Review Vol. 22 No.4 April 2001.

  ·        Eman Al Reyami, Khawla Al Zoabi, Aiman Rahmani, Mohammed Tamim, Fares Chedid:  (Is isolation of outborn infants required at admission to the neonatal intensive care unit),  AJIC: American Journal of Infection Control, Feb. 2009.

  ·        G. N. Bekdache, M. A. Hamdan, M. A. Begam, F. Chedid, M. M. Tamim, H. Mirghani: (Prenatal Diagnosis of Extrahepatic Umbilical Portosystemic Shunt: Impact on Postnatal Management), Journal of Obstetrics and Gynaecology; the Journal of the Institute of Obstetrics and Gynaecology Aug. 2011; 31(6): 542-3

Memberships

• The Middle East Critical Care Assembly
  AAP

See publications for Mohammed Morshed Tamim, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/2/2025, Dr. Tamim has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.